Shaw Timothy reported option exercise involving 9,981 derivative units of MARIMED INC. at $0.00 for $0 on Oct 2, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Operating Officer
Chief Operating Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
9,981Restricted Stock Units (RSU)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
9,982Direct
Trade date
Oct 2, 2026Option exercise
Filed
Oct 2, 2026, 4:06 PM ET0-day reporting delay
Accession
0001522767-26-000197Code M · Transaction 234307
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 2, 2026Option exercise9,981$0.00$0Trade 234305
Oct 2, 2026Tax withholding3,459$0.07−$240.75Trade 234306
3 transaction rows in this filing. Joint filers share the same rows.

MRMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MRMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 9, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: RSUs convert to shares of common stock on a one-for-one basis. F2: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. F3: The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. F4: The RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in full on April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.